Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway
Yu‐Jung Heo(Ajou University), Hae Jin Kim(Ajou University)
Cited by 18
Related Papers
Visfatin Induces Inflammation and Insulin Resistance via the NF-<i>κ</i>B and STAT3 Signaling Pathways in Hepatocytes
|Journal of Diabetes Research|2019|154
Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways
|Journal of Immunology Research|2021|131
Amphiregulin Induces iNOS and COX-2 Expression through NF-κB and MAPK Signaling in Hepatic Inflammation
|Mediators of Inflammation|2023|27
Empagliflozin Alleviates Hepatic Steatosis and Oxidative Stress via the NRF1 Pathway in High-Fat Diet-Induced Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease
|International Journal of Molecular Sciences|2025|5